FDA Food recall F-1523-2013
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
- FDA Food
- Class I
- terminated
- Published 2013-06-19
On 2013-06-19 the FDA classified a Class I recall of XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles by Atlantic Pro Nutrients, citing undeclared Soy and Milk on the label.
Read the official FDA Food notice
| Agency | FDA Food |
|---|---|
| Recall number | F-1523-2013 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2013-05-01 |
| Published | 2013-06-19 |
| Last updated | 2026-09-13 11:48 UTC |
| Company | Atlantic Pro Nutrients |
| Distribution | AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY |
Product
XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Reason
Undeclared Soy and Milk on the label.
Identifiers
| code_info | All SKUs |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:48 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/food/enforcement.json?search=recall_number:%22F-1523-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.